1. Home
  2. INSM vs AIZ Comparison

INSM vs AIZ Comparison

Compare INSM & AIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INSM
  • AIZ
  • Stock Information
  • Founded
  • INSM 1988
  • AIZ 1892
  • Country
  • INSM United States
  • AIZ United States
  • Employees
  • INSM N/A
  • AIZ N/A
  • Industry
  • INSM Biotechnology: Pharmaceutical Preparations
  • AIZ Property-Casualty Insurers
  • Sector
  • INSM Health Care
  • AIZ Finance
  • Exchange
  • INSM Nasdaq
  • AIZ Nasdaq
  • Market Cap
  • INSM 12.6B
  • AIZ 10.9B
  • IPO Year
  • INSM 2000
  • AIZ N/A
  • Fundamental
  • Price
  • INSM $69.73
  • AIZ $203.12
  • Analyst Decision
  • INSM Strong Buy
  • AIZ Strong Buy
  • Analyst Count
  • INSM 17
  • AIZ 6
  • Target Price
  • INSM $95.93
  • AIZ $231.33
  • AVG Volume (30 Days)
  • INSM 2.3M
  • AIZ 826.7K
  • Earning Date
  • INSM 05-08-2025
  • AIZ 05-06-2025
  • Dividend Yield
  • INSM N/A
  • AIZ 1.58%
  • EPS Growth
  • INSM N/A
  • AIZ N/A
  • EPS
  • INSM N/A
  • AIZ 12.82
  • Revenue
  • INSM $381,030,000.00
  • AIZ $12,071,400,000.00
  • Revenue This Year
  • INSM $29.15
  • AIZ $6.95
  • Revenue Next Year
  • INSM $115.02
  • AIZ $4.38
  • P/E Ratio
  • INSM N/A
  • AIZ $15.83
  • Revenue Growth
  • INSM 20.77
  • AIZ 6.18
  • 52 Week Low
  • INSM $53.69
  • AIZ $160.12
  • 52 Week High
  • INSM $84.91
  • AIZ $230.55
  • Technical
  • Relative Strength Index (RSI)
  • INSM 53.15
  • AIZ 56.53
  • Support Level
  • INSM $65.56
  • AIZ $197.30
  • Resistance Level
  • INSM $68.74
  • AIZ $201.59
  • Average True Range (ATR)
  • INSM 2.41
  • AIZ 4.91
  • MACD
  • INSM 0.42
  • AIZ 0.41
  • Stochastic Oscillator
  • INSM 76.91
  • AIZ 90.31

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

About AIZ Assurant Inc.

Assurant Inc offers a range of property-casualty, health, employee benefit, and warranty insurance to a client base made up of individuals and institutions. Its segments are Global Housing, Global lifestyle, Corporate and Other. Global Housing provides lender-placed homeowners insurance, lender-placed manufactured housing insurance and lender-placed flood insurance; renters insurance and related products; and voluntary manufactured housing insurance, voluntary homeowners insurance and other specialty products. Global Lifestyle, the key revenue-generating segment, provides mobile device solutions and extended service products and related services for mobile devices, consumer electronics and appliances; vehicle protection; and credit protection and other insurance products.

Share on Social Networks: